What you missed.(pharmaceutical industry lobbying against laws on direct to consumer advertising of drugs)(Staples Inc. retains MediaCom as advertising agency)(Federal Trade Commission praises entertainment industry for limiting marketing of violent movies)

Advertising Age, April, 2007

It's high noon on Capitol Hill. The congressional debate over direct-to-consumer drug advertising is due to kick off Wednesday and ad and pharmaceutical groups are increasing their lobbying efforts, desperately hoping to deflect the attack against a segment that generates $4.5 billion in ads annually. The proposed legislation could allow the Food and Drug Administration to ban DTC ads for the first two years of a new drug. It would also require ads for new drugs to carry additional warnings and a statement that the drug has just recently been approved and all risks may not be known.

Office supply-giant Staples has elected to keep its $128 million media-buying account with WPP Group's MediaCom, according to people familiar with the business. Interpublic Group of...

Read the rest of this article with a Free Trial at HighBeam Research.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works.